Micron Biomedical
Atlanta, United States · Biotechnology, Health Care · 22 employees
Micron Biomedical, Inc. is a clinical-stage biopharmaceutical company on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary patch technology that simplifies and improves the way actives are delivered, stored, and distributed. This technology is designed to increase patient access to drugs and vaccines that would otherwise require expert injection and to impro
Funding history
- Venture - Series Unknown — $15.0M — Dec 2024
- Seed — $3.0M — Apr 2023
- Venture - Series Unknown — $14.0M — Dec 2022
- Series A — Undisclosed — Nov 2022
Recent signals
- Jan 07, 2025: Micron Biomedical Secures $43 Million Grant to Improve Measles and Rubella Vaccine Coverage
- Dec 26, 2024: Raised $15.0M in Venture - Series Unknown
- Apr 17, 2023: Raised $3.0M in Seed
- Dec 07, 2022: Raised $14.0M in Venture - Series Unknown
- Nov 28, 2022: Raised funding in Series A
See plans & pricing → Track Micron Biomedical’s funding, hiring, and signals — with verified contacts — on Fundz.